Cite
HARVARD Citation
Symonds, L. et al. (2022). Evaluation of methylated DCR1 as a biomarker for response to adjuvant irinotecan-based therapy in stage III colon cancer: cancer and leukaemia Group B 89803 (Alliance). Epigenetics. 17 (12), pp. 1715-1725. [Online].